Design, synthesis, modeling studies and biological evaluation of pyrazole derivatives linked to oxime and nitrate moieties as nitric oxide donor selective COX-2 and aromatase inhibitors with dual anti-inflammatory and anti-neoplastic activities
- 19 February 2023
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 134, 106428
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-lifeBioorganic & Medicinal Chemistry Letters, 2010
- Highly Potent First Examples of Dual Aromatase−Steroid Sulfatase Inhibitors based on a Biphenyl TemplateJournal of Medicinal Chemistry, 2010
- The reemergence of nitric oxide and cancerNitric Oxide, 2008
- O2-Acetoxymethyl-protected diazeniumdiolate-based NSAIDs (NONO–NSAIDs): Synthesis, nitric oxide release, and biological evaluation studiesBioorganic & Medicinal Chemistry, 2007
- NO-Donor COX-2 Inhibitors. New Nitrooxy-Substituted 1,5-Diarylimidazoles Endowed with COX-2 Inhibitory and Vasodilator PropertiesJournal of Medicinal Chemistry, 2007
- Cyclooxygenase: Past, present and future. A tribute to John R. Vane (1927–2004)Journal of Thermal Biology, 2006
- NSAID-Associated Adverse Effects and Acid Control Aids to Prevent ThemDrug Safety, 2006
- Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention TrialNew England Journal of Medicine, 2005
- Assessment of non‐steroidal anti‐inflammatory drug (NSAID) damage in the human gastrointestinal tractBritish Journal of Clinical Pharmacology, 2003
- Genetic induction and upregulation of cyclooxygenase (COX) and aromatase (CYP19): an extension of the dietary fat hypothesis of breast cancerMedical Hypotheses, 1999